ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

ELIZABETH WHITE MD

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,850Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 113

$581K Total Retail Price of All Prescriptions

Rank: 18 out of 113

353 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 353 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 353 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 5,541 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
OMEPRAZOLE 392 255 1 5
HYDROCODONE-ACETAMINOPHEN 361 214 S3 2 7
LEVOTHYROXINE SODIUM 316 194 3 1
FUROSEMIDE 314 259 4 6
SIMVASTATIN 269 177 5 2
LISINOPRIL 249 196 6 3
WARFARIN SODIUM 213 157 7 8
AMLODIPINE BESYLATE 201 157 8 4
POTASSIUM CHLORIDE 192 135 9 12
GABAPENTIN 185 89 10 18
METOPROLOL TARTRATE 171 138 11 14
CYMBALTA 160 108 12 37
FENTANYL 155 98 S2 13 43
METOPROLOL SUCCINATE 151 128 14 10
HYDROCHLOROTHIAZIDE 122 91 15 9
METFORMIN HCL 117 59 16 11
CITALOPRAM HBR 117 114 16 17
ATENOLOL 117 66 16 16
LOSARTAN POTASSIUM 107 106 19 13
ZOLPIDEM TARTRATE 104 64 20 19
TRAZODONE HCL 93 70 21 41
GLYBURIDE 83 22 R 22 66
OXYCODONE HCL 79 19 S2 23 62
PREDNISONE 76 34 24 28
OLANZAPINE 72 62 25 88
ATORVASTATIN CALCIUM 69 59 26 15
PANTOPRAZOLE SODIUM 68 35 27 52
PAROXETINE HCL 63 47 28 45
ADVAIR DISKUS 60 21 29 35
CARVEDILOL 59 49 30 25
SPIRONOLACTONE 59 33 30 32
LYRICA 58 32 32 83
FLUOXETINE HCL 58 38 32 31
TAMSULOSIN HCL 58 42 32 24
MORPHINE SULFATE ER 57 12 S2 35 79
VENLAFAXINE HCL ER 56 37 36 55
PROPRANOLOL HCL 56 19 36 92
GLIPIZIDE 55 35 38 75
JANUVIA 52 19 39 85
MELOXICAM 51 25 40 44
COMBIVENT 50 16 41 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 12, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.